Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000818

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2020 · Mar 31, 2020 −$59
Cash And Equivalents Q2 2020 · Mar 31, 2020 $0
Stockholders Equity Q2 2020 · Mar 31, 2020 −$242.13K
Stockholders Equity Q2 2020 · Dec 31, 2019 −$238.61K
Stockholders Equity Q2 2020 · Sep 30, 2019 −$235.09K
Current Liabilities Q2 2020 · Mar 31, 2020 $242.6K
Current Liabilities Q2 2020 · Sep 30, 2019 $235.61K
Total Liabilities Q2 2020 · Mar 31, 2020 $242.6K
Total Liabilities Q2 2020 · Sep 30, 2019 $235.61K
Current Assets Q2 2020 · Mar 31, 2020 $468
Current Assets Q2 2020 · Sep 30, 2019 $527
Total Assets Q2 2020 · Mar 31, 2020 $468
Total Assets Q2 2020 · Sep 30, 2019 $527
Net Income Q2 2020 · Mar 31, 2020 −$3.53K
Net Income Q2 2020 · Mar 31, 2020 −$7.05K
Net Income Q2 2020 · Dec 31, 2019 −$3.52K
Operating Income Q2 2020 · Mar 31, 2020 −$2.31K
Operating Income Q2 2020 · Mar 31, 2019 −$1.77K